• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

CELGZ:US

2.5900 USD 0.0300 1.15%

As of 20:10:00 ET on 07/24/2014.

Snapshot for Celgene Corp (CELGZ)

Open: 2.6200 Day's Range: 2.5499 - 2.6200 Volume: 17,250
Previous Close: 2.6200 52wk Range: 0.9833 - 3.5500 1-Yr Rtn: +33.04%

Stock Chart for CELGZ

No chart data available.
  • CELGZ:US 2.5900
  • 1D
  • 1M
  • 1Y
2.6200
Interactive CELGZ Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CELGZ

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 0.00
Shares Outstanding (M) 43.00
30 Day Average Volume 9,075
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend (USD) 6.9326
Dividend Ex-Date 10/08/2013
5 Year Dividend Growth -
Next Earnings Announcement 07/24/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CELGZ

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CELGZ

Celgene Corporation is a global biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases.

Robert J Hugin "Bob"Chairman/President/CEOMark J AllesExec VP/Head:Hematology
Jacqualyn A Fouse "Jackie"Exec VP/CFOPeter N KelloggExecutive Vice President
More Company Profile & Key Executives for CELGZ

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil